The Connection Between Infrared Radiation and Cancer

Infrared radiation does not cause cancer the way ultraviolet light does, but its relationship with the disease is far more layered than a simple yes-or-no safety question. Infrared wavelengths lack the energy to directly break DNA strands, yet they interact with living tissue in ways that matter for both cancer risk and cancer treatment. Researchers are now harnessing infrared light to destroy tumors, guide surgeons during operations, trigger precision drug release, and ease the side effects of chemotherapy, while a smaller body of work examines how solar infrared exposure might quietly assist ultraviolet light in damaging skin.

Can Infrared Radiation Cause Cancer on Its Own?

Infrared photons carry less energy per photon than visible light, and far less than ultraviolet or X-ray photons. That puts infrared squarely in the non-ionizing part of the electromagnetic spectrum, meaning it cannot rip electrons off molecules or snap DNA strands the way ionizing radiation can. On its own, there is no strong evidence that infrared exposure initiates the kind of genetic mutations that set cancer in motion.

The picture gets more complicated when infrared light is combined with the rest of the solar spectrum. Experiments exposing human skin cells to isolated components of sunlight found that ultraviolet, visible, and infrared light together produced a synergistic spike in reactive oxygen species in dermal fibroblasts, greater than any component alone. The effect was statistically strong but did not appear in the outermost skin cells (keratinocytes), suggesting that infrared’s contribution to solar skin damage is real but limited in scope and cell type.¹ Reactive oxygen species can cause oxidative DNA damage over time, so this synergy is worth knowing about. But the driving force behind sun-related skin cancer remains ultraviolet radiation. Infrared appears to play a supporting role at most, amplifying oxidative stress rather than independently corrupting the genome.

Low-Level Infrared Light Therapy and Tumor Safety

Red and near-infrared light devices are widely marketed for skin rejuvenation, wound healing, and pain relief. A reasonable worry is whether shining these wavelengths on or near a tumor could accelerate its growth. The research here is reassuring with an important caveat.

A systematic review of photobiomodulation’s oncologic safety found that, within the parameters typically used in clinics, red and near-infrared light mainly enhanced healthy cell growth while either reducing the proliferation of cancer cells or having no measurable effect. The review also found no clinical trial data linking photobiomodulation to the development of new tumors or recurrence of existing ones.² An earlier animal study that applied low-level laser therapy directly to tumors found no measurable increase in tumor growth, concluding that the therapy appeared safe even in the presence of malignant lesions.³

The caveat is wavelength specificity. A study testing photobiomodulation on melanoma cells found that 808 nm near-infrared light significantly promoted both proliferation and migration of melanoma cells in the lab, and in live mice it increased tumor volume and triggered blood vessel growth within the tumor.⁴ Other wavelengths tested did not show this effect, meaning the risk is not blanket but wavelength-dependent. This finding matters for anyone with a known melanoma who is considering light therapy: not all near-infrared wavelengths are equal, and the safety profile depends on the exact parameters used.

Far-Infrared Radiation and Cancer Cells

Far-infrared radiation sits at the long-wavelength end of the infrared spectrum, well beyond what most consumer light-therapy devices emit. It is the kind of heat you feel from a ceramic heater or an infrared sauna. Several lab studies suggest it may actually inhibit cancer cell growth rather than promote it.

One study found that far-infrared irradiation significantly slowed breast cancer cell proliferation and colony formation without killing cells outright. Importantly, no DNA damage was detected, ruling out the sort of genetic harm associated with ionizing radiation. The mechanism appeared to involve a calcium-signaling pathway in the nucleus that activated a checkpoint protein, essentially telling the cancer cells to stop dividing.⁵ A separate study on melanoma cells showed that far-infrared treatment suppressed proliferation, triggered programmed cell death, and arrested cells in the resting phase of their growth cycle.⁶

Earlier work showed that whether far-infrared radiation inhibits cancer cell growth depends in part on heat-shock proteins already present in the cell. Cells with low baseline levels of a particular heat-shock protein were more susceptible to growth arrest from far-infrared exposure, while cells with high levels resisted it.⁷ All of these findings come from cell cultures or animal models, so they should not be read as proof that infrared saunas treat cancer. They do suggest that far-infrared wavelengths are not a hidden carcinogen and may even have properties worth investigating further.

Killing Tumors with Infrared-Heated Nanoparticles

One of the most active areas of infrared cancer research is photothermal therapy, in which tiny gold particles are delivered to a tumor and then heated by near-infrared laser light. Near-infrared wavelengths penetrate tissue more deeply than visible light, making it possible to reach tumors beneath the skin surface. When the gold nanoparticles absorb the laser energy, they convert it into heat intense enough to destroy surrounding cancer cells.⁸

Gold-based particles are favored for several reasons: they are biocompatible, small enough to accumulate in tumors when injected into the bloodstream, and can be engineered to absorb specific near-infrared wavelengths by adjusting their shape and size.⁹ Researchers have also coated gold nanorods with antibodies that target specific proteins on cancer cells, making the therapy more selective. In one study, antibody-targeted gold nanorods combined with near-infrared laser treatment induced a form of cell death in triple-negative breast cancer cells both in culture and in mouse tumors.¹⁰ The appeal of the approach is precision: the heat is generated only where the nanoparticles have accumulated, potentially sparing the healthy tissue nearby.

Near-Infrared Photoimmunotherapy

A newer strategy goes beyond simply cooking tumor cells. Near-infrared photoimmunotherapy, or NIR-PIT, uses an antibody-dye conjugate that binds to proteins on the cancer cell surface. When near-infrared light hits the dye, the targeted cancer cell membrane ruptures within minutes. What happens next is what makes this approach distinctive: the burst cell spills its internal contents, including cancer-specific proteins, into the surrounding tissue.¹¹

Those released proteins act as signals that alert the immune system. Immune cells in the area mature rapidly, learn to recognize the cancer antigens, and then multiply. The result is an immune response that can attack not only the treated tumor but also untreated tumors of the same type elsewhere in the body. The released cellular contents trigger a cascade that includes activation of antigen-presenting cells, expansion of cancer-specific killer T cells, and the upregulation of stress-related proteins that further amplify the immune alarm.¹² In essence, the infrared light turns a local tumor destruction event into a body-wide immune training session.

Reaching Deep Tumors with Photodynamic Therapy

Photodynamic therapy uses light to activate a photosensitizer chemical that generates toxic oxygen species capable of killing cancer cells. The traditional problem is that the photosensitizers respond to visible or ultraviolet light, neither of which penetrates deeply into tissue. Near-infrared light solves that penetration problem, but most photosensitizers do not absorb it directly.

The workaround involves upconversion nanoparticles, tiny crystals that absorb near-infrared photons and re-emit them as higher-energy visible light right at the tumor site. That visible light then activates the photosensitizer locally. In animal studies, this NIR-triggered approach achieved a tumor inhibition ratio of about 50%, nearly three times better than conventional visible-light photodynamic therapy applied to the same deep-seated tumors.¹³ The same upconversion principle can be used to trigger drug release or activate imaging molecules deep inside the body.¹⁴

Researchers are now pushing into even longer near-infrared wavelengths, sometimes called the “second near-infrared window,” which penetrate tissue more deeply and produce less background interference. Photosensitizers responsive to these longer wavelengths show potential for treating tumors that sit well below the surface.¹⁵ One research group even used upconversion nanoparticles to convert near-infrared light into blue light inside living mice, controlling an optogenetic switch that triggered cancer cell death on command.¹⁶

Triggering Drug Release with Near-Infrared Light

Getting chemotherapy drugs to the right place at the right time remains one of oncology’s persistent challenges. Near-infrared light offers a potential trigger mechanism because it passes harmlessly through healthy tissue at controlled doses and exposure times.¹⁷ The concept: load a drug into a nanoparticle carrier, inject it, wait for the carrier to accumulate in the tumor, then shine a near-infrared laser to release the payload exactly where it is needed.

Several groups have demonstrated this in the lab. One approach conjugated two breast cancer drugs to gold nanoshells and showed that pulsed near-infrared laser light could release the drug in a way that killed cancer cells while leaving non-cancerous control cells unaffected.¹⁸ Another system combined a photothermal dye with a chemotherapy agent inside a nanoparticle designed to respond to reactive oxygen species; near-infrared irradiation both heated the tumor and sped up drug release simultaneously.¹⁹ These dual-action systems offer the promise of combining heat-based tumor destruction with chemotherapy in a single treatment step, potentially reducing the systemic side effects that come with flooding the whole body with toxic drugs.

Using Infrared Light to Find and Map Tumors

Infrared radiation also has a diagnostic side. Tumors tend to generate more metabolic heat and recruit more blood vessels than surrounding tissue, producing a slightly warmer surface temperature. Infrared thermography detects these temperature differences using thermal cameras, entirely without radiation exposure. A recent comparative evaluation found that thermography showed high specificity and strong positive predictive value for breast cancer, though its sensitivity was too low for standalone screening. The authors suggested it could serve as a supplementary tool, especially in low-resource settings and among younger women with dense breast tissue where mammography performs less reliably.²⁰ A critical review noted that newer-generation thermal cameras combined with artificial intelligence have reported sensitivity and specificity values approaching those of mammography, though adoption by radiologists has been slow.²¹

Inside the operating room, near-infrared fluorescence imaging is becoming a practical tool for surgeons. A fluorescent dye (most commonly indocyanine green) is injected and then visualized with a near-infrared camera, revealing blood flow, lymph nodes, and tumor margins in real time. This approach has been shown to reduce operative times, improve how well surgeons can see anatomical structures, and increase the accuracy of tumor removal.²² In breast-conserving surgery, researchers have developed a probe that targets a specific protein on breast cancer cells, enabling rapid assessment of surgical margins to confirm that all cancerous tissue has been removed.²³

Easing the Side Effects of Cancer Treatment

Oral mucositis, the painful inflammation and ulceration of the mouth lining that often accompanies chemotherapy and radiation therapy, is one of the most dreaded side effects cancer patients face. Near-infrared light therapy has emerged as a practical tool for managing it. A review described photobiomodulation therapy as an effective modality that can improve quality of life by reducing these side effects.²⁴ In bone marrow transplant patients, application of near-infrared LED devices to the outside of the cheeks led to a significant reduction in patient-reported mouth pain compared to the control group.²⁵ This is one of the most clinically established uses of infrared light in oncology, already recommended by some cancer treatment guidelines as a supportive care measure.

How Infrared-Induced Heat Makes Radiation Therapy Hit Harder

Heating a tumor to moderate temperatures, a practice called hyperthermia, has long been known to boost the effectiveness of radiation therapy. The biological reason is that heat interferes with the DNA repair machinery cancer cells rely on to survive radiation damage. Specifically, mild heating degrades a key protein involved in homologous recombination, one of the major pathways cells use to fix broken DNA strands.²⁶ Without that repair pathway working properly, cancer cells accumulate lethal amounts of DNA damage from what would otherwise be a survivable dose of radiation.

Experiments on human melanoma cells showed that one hour of heating after irradiation partially blocked the repair of DNA double-strand breaks, and at higher temperatures the block was complete.²⁷ This has opened the door to combination strategies: heat a tumor with infrared-absorbing nanoparticles or focused infrared devices, then deliver radiation or chemotherapy drugs that exploit the resulting repair deficiency.²⁸ Infrared light is a natural fit for the heating step because it can be delivered non-invasively and focused on a target area, and when combined with nanoparticles that concentrate the heat inside the tumor, the surrounding tissue sees relatively little thermal damage.

Wavelength Matters More Than “Infrared” as a Category

One theme running through all of this research is that “infrared” is not a single thing. The infrared spectrum stretches from about 700 nanometers to over a million nanometers, and different slices of that range interact with tissue in completely different ways. Near-infrared wavelengths around 810 nm can boost the activity of an enzyme in mitochondria, while wavelengths at 750 nm and 950 nm actually reduce the same enzyme’s activity and dial down mitochondrial energy production.²⁹ That level of wavelength specificity matters enormously when the question is whether a given infrared exposure helps or harms cancer cells.

Far-infrared wavelengths, which barely penetrate the skin, appear to slow cancer cell division without causing DNA damage. Near-infrared wavelengths penetrate several centimeters, making them useful for heating nanoparticles deep in tissue. One specific near-infrared wavelength promoted melanoma growth in a lab model while others at slightly different wavelengths did not. The practical lesson for anyone encountering claims about infrared and cancer is to ask which wavelengths, at what intensity, and for how long. A blanket statement that “infrared causes cancer” or “infrared cures cancer” ignores the diversity of a spectrum that spans orders of magnitude in photon energy and tissue penetration, and the biological response to each slice can be entirely different.